Enzo Biochem (ENZ) Competitors

Quipt Home Medical (NASDAQ:QIPT) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

Does the MarketBeat Community believe in QIPT or ENZ?

Enzo Biochem received 181 more outperform votes than Quipt Home Medical when rated by MarketBeat users. However, 83.78% of users gave Quipt Home Medical an outperform vote while only 53.00% of users gave Enzo Biochem an outperform vote.

Company	Underperform	Outperform
Quipt Home Medical	Outperform Votes 31 83.78%	Underperform Votes 6 16.22%
Enzo Biochem	Outperform Votes 212 53.00%	Underperform Votes 188 47.00%

Do analysts rate QIPT or ENZ?

Quipt Home Medical presently has a consensus price target of $6.25, indicating a potential upside of 169.40%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Quipt Home Medical is more favorable than Enzo Biochem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quipt Home Medical	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00
Enzo Biochem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility & risk, QIPT or ENZ?

Quipt Home Medical has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Which has higher valuation and earnings, QIPT or ENZ?

Quipt Home Medical has higher revenue and earnings than Enzo Biochem.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quipt Home Medical	$244.72M	0.41	-$6.76M	-$0.17	-13.65
Enzo Biochem	$29.09M	0.78	-$26.08M	N/A	N/A

Is QIPT or ENZ more profitable?

Quipt Home Medical has a net margin of -2.90% compared to Enzo Biochem's net margin of -75.34%. Quipt Home Medical's return on equity of -6.70% beat Enzo Biochem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quipt Home Medical	-2.90%	-6.70%	-2.94%
Enzo Biochem	-75.34%	-7.96%	-5.49%

Does the media refer more to QIPT or ENZ?

In the previous week, Enzo Biochem had 2 more articles in the media than Quipt Home Medical. MarketBeat recorded 4 mentions for Enzo Biochem and 2 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of 0.73 beat Enzo Biochem's score of 0.00 indicating that Quipt Home Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quipt Home Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enzo Biochem	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals have more ownership in QIPT or ENZ?

42.8% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 13.4% of Quipt Home Medical shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Quipt Home Medical beats Enzo Biochem on 13 of the 17 factors compared between the two stocks.